### The Science of NanoBase™

NanoBase™ is not an emulsion. It is a molecularly engineered tri-domain nano-delivery platform, operating at a scale where the classical Hydrophilic-Lipophilic Balance (HLB) rules of macro-emulsion physics no longer govern behavior. Legacy topical systems depend on surfactant geometry to force oil and water into metastable suspension. Those systems fail at the stratum corneum — the 15–20 µm lipid barrier that is evolutionarily engineered to reject foreign molecules above approximately 500 Daltons.

NanoBase™ is engineered beneath that threshold.

### The Tri-Domain Architecture

Every NanoBase™ variant is constructed around three simultaneously stabilized molecular domains:

Domain 1 — Aqueous Interior. Hosts water-soluble actives (peptides, ascorbate derivatives, niacinamide, glycosaminoglycan fragments) in a hydration-stable reservoir. Osmotic pressure is matched to interstitial dermal fluid (~290 mOsm/kg) to prevent payload flash-release on application.

Domain 2 — Lipidic Shell. A bilayer of biomimetic lipids — principally ceramides (NP, AP, EOP), cholesterol, and free fatty acids at the native 3:1:1 stratum corneum ratio — that functions as both carrier and penetration vector. The shell is recognized by the skin's endogenous lipid lamellae as self, bypassing the barrier's rejection kinetics.

Domain 3 — Amphipathic Interface. A surfactant-adjacent monolayer engineered from phosphatidylcholine derivatives and natural cationic peptides. This domain is the molecular engineering target of NanoBase™ — its precise geometry determines particle size distribution, zeta potential, and release kinetics.

### Particle Size and Penetration Depth

NanoBase™ platforms operate within a tightly controlled 80–180 nm hydrodynamic diameter range, measured by dynamic light scattering (DLS) with a polydispersity index (PDI) consistently below 0.2. This places the delivered payload below the 500 Dalton passive-diffusion ceiling and within the 20–200 nm window empirically correlated with follicular and intercellular lipid-route penetration to the viable epidermis.

Confocal Raman spectroscopy penetration profiles for the NanoBase™ Cortex and NanoBase™ Rx architectures demonstrate active-molecule presence at stratum basale depth (60–80 µm) within 90 minutes of topical application — a regime unreachable by macro-emulsion carriers.

### Pharmacokinetic Stability

Unlike conventional liposomes, which exhibit payload leakage half-lives of 6–48 hours at ambient storage, NanoBase™ tri-domain particles maintain >95% payload retention across 18 months at 25 °C / 60% RH (ICH Q1A zone II conditions). This stability is a direct function of the cholesterol-modulated lipid bilayer rigidity and the amphipathic interface's lateral phase coherence.

### Variant Architecture

The eight NanoBase™ variants — Aroma, Classic, Cleanse, Clinical, Cortex, Epilingual, Luxe, and Rx — are not different products in the conventional sense. They are parameter-tuned expressions of the same tri-domain architecture, each optimized for a specific payload class, anatomical target, or regulatory tier.

- NanoBase™ Classic — foundational tri-domain daily delivery.

- NanoBase™ Aroma — volatile-active stabilization for terpene and ester olfactives.

- NanoBase™ Cleanse — surfactant-compatible architecture for rinse-off and leave-on cleansing.

- NanoBase™ Clinical — concentrated-active platform for in-clinic and post-procedure use.

- NanoBase™ Cortex — deep-penetration tuning for transdermal cortical thresholds.

- NanoBase™ Epilingual — mucosal-compatible formulation for epilingual and oral-cavity routes.

- NanoBase™ Luxe — prestige-tier sensorial optimization with preserved pharmacokinetic performance.

- NanoBase™ Rx — pharmaceutical-grade platform built on the TDLLC (Tri-Domain Lipid-Liquid Crystal) excipient for prescription dermatological actives.

### Scholarly Reference

The foundational scientific treatment of the NanoBase™ platform — including synthesis protocols, DLS and cryo-TEM characterization data, ICH-aligned stability studies, and in-vitro penetration kinetics — is published openly under:

> Pensive Beauty® Nanoscience Labs (2025). NanoBase™: A Tri-Domain Nano-Delivery Platform for Cosmeceutical and Pharmaceutical Topical Applications. Zenodo. [https://doi.org/10.5281/zenodo.18616576](https://doi.org/10.5281/zenodo.18616576)

This is the canonical citation for all academic, regulatory, and formulation-partner reference.

### Why This Matters

Most topicals fail not at the formulation bench but at the stratum corneum. The cosmeceutical industry's reliance on macro-emulsion physics — governed by HLB values calibrated for 1950s-era surfactant chemistry — produces products whose actives are, in measurable terms, never delivered. NanoBase™ was engineered to resolve that failure at the molecular level. The platform is the delivery system; the actives are the payload. Once that separation is understood, formulation becomes pharmacology.